Order Article Reprints

Fischer J, Wellhöner S, Ebel S, Lincke T, Böhlig A, Gerhardt F, Veelken R, Goessmann H, Steinhoff KG, Denecke T, et al. The Liver Maximum Capacity Test (LiMAx) Is Associated with Short-Term Survival in Patients with Early Stage HCC Undergoing Transarterial Treatment. Cancers. 2022; 14(21):5323. https://doi.org/10.3390/cancers14215323

Fischer, Janett, Stella Wellhöner, Sebastian Ebel, Thomas Lincke, Albrecht Böhlig, Florian Gerhardt, Rhea Veelken, Holger Goessmann, Karen Geva Steinhoff, Timm Denecke, and et al. 2022. "The Liver Maximum Capacity Test (LiMAx) Is Associated with Short-Term Survival in Patients with Early Stage HCC Undergoing Transarterial Treatment" Cancers 14, no. 21: 5323. https://doi.org/10.3390/cancers14215323

Fischer, J., Wellhöner, S., Ebel, S., Lincke, T., Böhlig, A., Gerhardt, F., Veelken, R., Goessmann, H., Steinhoff, K. G., Denecke, T., Sabri, O., Berg, T., & Bömmel, F. v. (2022). The Liver Maximum Capacity Test (LiMAx) Is Associated with Short-Term Survival in Patients with Early Stage HCC Undergoing Transarterial Treatment. Cancers, 14(21), 5323. https://doi.org/10.3390/cancers14215323